The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Clinical features and natural history of progressive supranuclear palsy: A clinical cohort study
Abstract
OBJECTIVE: To describe clinical features and identify prognostic predictors in progressive supranuclear palsy (PSP). METHODS: Record-based diagnosis according to National Institute of Neurological Disorders and Stroke-Society for Progressive Supranuclear Palsy criteria was performed in 187 cases of PSP. Clinical information was abstracted from patient records. Sixty-two patients (33%) were examined by the investigators. Forty-nine of 62 patients (79%) underwent standardized clinical assessment. Predictors of survival were examined after a mean of 6.4 years. RESULTS: The most common symptoms at disease onset related to mobility (69%). Of patients undergoing standardized clinical assessment, diplopia occurred in 61%, photophobia in 43%, and eyelid apraxia in 43%. Seventy-five cases (40%) died during follow-up. Older age at onset and classification as probable PSP were associated with poorer survival. Onset of falls (hazard ratio 3.28, 95% CI 1.17 to 9.13), speech problems (hazard ratio 4.74, 95% CI 1.10 to 20.4), or diplopia (hazard ratio 4.23, 95% CI 1.23 to 14.6) within 1 year and swallowing problems within 2 years (hazard ratio 3.91, 95% CI 1.39 to 11.0) were associated with a worse prognosis. CONCLUSIONS: Mobility problems are the commonest early feature in PSP and visual symptoms are often functionally disabling. Early falls, speech and swallowing problems, diplopia, and early insertion of a percutaneous gastrostomy predict reduced survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Hauw, J.-J., Daniel, S. E., Dickson, D., Horoupian, D. S., Jellinger, K., Lantos, P. L., McKee, A., Tabaton, M., & Litvan, I. (1994) · Neurology · doi:10.1212/wnl.44.11.2015 · Cited by 852
Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study
Schrag, A., Ben-Shlomo, Y., & Quinn, N. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04137-9 · Cited by 642
Self-citationLitvan, I., Mangone, C. A., McKee, A., Verny, M., Parsa, A., Jellinger, K., D'Olhaberriague, L., Chaudhuri, K. R., & Pearce, R. K. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.6.615 · Cited by 410
Prevalence and natural history of progressive supranuclear palsy
Golbe, L. I., Davis, P. H., Schoenberg, B. S., & Duvoisin, R. C. (1988) · Neurology · doi:10.1212/wnl.38.7.1031 · Cited by 309
Daniel, S. E., de Bruin, V. M. S., & Lees, A. J. (1995) · Brain · doi:10.1093/brain/118.3.759 · Cited by 274
Self-citationThe prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK
Nath, U. (2001) · Brain · doi:10.1093/brain/124.7.1438 · Cited by 252
Self-citationMaher, E. R., & Lees, A. J. (1986) · Neurology · doi:10.1212/wnl.36.7.1005 · Cited by 234
Self-citationProgressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.
Collins, S. J., Ahlskog, J. E., Parisi, J. E., & Maraganore, D. M. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.2.167 · Cited by 204
Progression of falls in postmortem-confirmed Parkinsonian disorders
Wenning, G. K., Ebersbach, G., Verny, M., Chaudhuri, К. R., Jellinger, K. A., McKee, A. C., Poewe, W. H., & Litvan, I. (1999) · Movement Disorders · Cited by 152
Cited by
Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges
Williams, D. R., & Lees, A. J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70042-0 · Cited by 650
Self-citationA clinical rating scale for progressive supranuclear palsy
Golbe, L. I., & Ohman-Strickland, P. A. (2007) · Brain · doi:10.1093/brain/awm032 · Cited by 614
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study
Bensimon, G., Ludolph, A., Agid, Y., Vidailhet, M., Payan, C., & Leigh, P. N. (2009) · Brain · doi:10.1093/brain/awn291 · Cited by 347
Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease
Lee, Y. C., Williams, D. R., & Anderson, J. F. I. (2016) · Journal of Neuropsychology · doi:10.1111/jnp.12053 · Cited by 26
Clinical, MRI and 18F-FDG-PET/CT analysis of progressive supranuclear palsy
Zhao, P., Zhang, B., Gao, S., & Li, X. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.06.008 · Cited by 20
Metadata
- Authors
- Nath, U., Ben-Shlomo, Y., Thomson, R. G., Lees, A. J., & Burn, D. J.
- Venue
- Neurology
- Published
- 2003-03-25
- Volume
- 60
- Issue
- 6
- Pages
- 910-916
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2007566464
- Cited by
- 281
- References
- 17
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical features and natural history of progressive supranuclear palsy: A clinical cohort study. https://app.cochat.ai/papers/10.1212/01.wnl.0000052991.70149.68
- The paper
- Nath, U., Ben-Shlomo, Y., Thomson, R. G., Lees, A. J., & Burn, D. J. (2003). Clinical features and natural history of progressive supranuclear palsy: A clinical cohort study. Neurology. https://doi.org/10.1212/01.wnl.0000052991.70149.68
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.